[HTML][HTML] Harnessing epigenetics for breast cancer therapy: The role of DNA methylation, histone modifications, and MicroRNA

J Szczepanek, M Skorupa, J Jarkiewicz-Tretyn… - International Journal of …, 2023 - mdpi.com
Breast cancer exhibits various epigenetic abnormalities that regulate gene expression and
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …

The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance

A Nandi, R Chakrabarti - Genes & development, 2020 - genesdev.cshlp.org
Breast cancer is the second leading cause of cancer-related death in women and is a
complex disease with high intratumoral and intertumoral heterogeneity. Such heterogeneity …

[HTML][HTML] Breast cancer prediction using different machine learning methods applying multi factors

E Nazari, H Naderi, M Tabadkani… - Journal of Cancer …, 2023 - Springer
Objective Breast cancer (BC) is a multifactorial disease and is one of the most common
cancers globally. This study aimed to compare different machine learning (ML) techniques to …

Therapeutics strategies against cancer stem cell in breast cancer

F Ghasemi, PZ Sarabi, SS Athari… - The international journal …, 2019 - Elsevier
Breast cancer is known as a most prevalent cancer and second deadly cancer, among
women worldwide. Due to the high incidence rate of breast cancer and limitations of …

Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways

A Tajbakhsh, M Hasanzadeh, M Rezaee… - Journal of cellular …, 2018 - Wiley Online Library
Breast cancer is among the most important causes of cancer related death in women. There
is a need for novel agents for targeting key signaling pathways to either improve the efficacy …

The 9p21 locus: A potential therapeutic target and prognostic marker in breast cancer

M Rivandi, MS Khorrami, H Fiuji… - Journal of cellular …, 2018 - Wiley Online Library
Breast cancer is an important cause of cancer related mortality in women. Despite extensive
efforts to identify valid biomarkers for risk stratification, there are relatively few with proven …

Lactate is a potential promoter of tamoxifen resistance in MCF7 cells

V Rossi, M Govoni, F Farabegoli… - Biochimica et Biophysica …, 2022 - Elsevier
Background Tamoxifen is a widely used estrogen receptor inhibitor, whose clinical success
is limited by the development of acquired resistance. This compound was also found to …

Characterization of the first microRNA in human CDH1 that affects cell cycle and apoptosis and indicates breast cancers progression

S Gharbi, Z Mohammadi, MS Dezaki… - Journal of Cellular …, 2022 - Wiley Online Library
The E‐cadherin protein (Cadherin 1, gene: CDH1), a master regulator of the human
epithelial homeostasis, contributes to the epithelial‐mesenchymal transition (EMT) which …

Association of a genetic variant in chromosome 9p21 with increased risk of developing cervical cancer

M Atabati, R Saber, P Malakuti… - Current Cancer …, 2023 - ingentaconnect.com
Background: Cervical cancer is one of the most prevalent gynecologic cancers associated
with high morbidity and mortality worldwide. There is mounting evidence indicating an …

Evaluation of the two polymorphisms rs1801133 in MTHFR and rs10811661 in CDKN2A/B in breast cancer

A Hesari, A Maleksabet, AN Tirkani… - Journal of cellular …, 2019 - Wiley Online Library
Abstract The 5, 10‐Methylenetetrahydrofolate reductase (MTHFR) was the rate‐limiting
enzyme in the methyl cycle, which was encoded by the MTHFR gene. MTHFR played a key …